Wells Fargo profit slumps 26% on legal costs
Wells Fargo & Co reported a 26% slump in quarterly profit on Tuesday, as mortgage income sank and it braced for additional legal expenses tied to a sales practices scandal that erupted more than three years ago.
Stocks struggle higher on Brexit hopes as trade optimism fades
Global stocks edged higher on Tuesday yet safe havens were still in play as markets tried to balance fading optimism over the latest China-U.S. trade truce with the likelihood of a Brexit deal by Thursday’s European Union summit.
JPMorgan beats profit estimates on strength in bond trading, underwriting
JPMorgan Chase & Co beat Wall Street estimates for quarterly profit by a wide margin on Tuesday, underpinned by strength in bond trading and underwriting.
UnitedHealth raises profit view as revenue from pharmacy benefits grows
UnitedHealth Group Inc on Tuesday raised its 2019 earnings forecast for the third time this year, bolstered by higher revenue at its unit that manages pharmacy benefits as well as its core health insurance business.
Goldman profit misses estimates on weak underwriting, M&A
Goldman Sachs Group Inc missed Wall Street estimates for quarterly profit on Tuesday, hit by lower fees from advising on deals and weakness in underwriting.
Prescription drugs boost drives J&J forecasts higher, shares rise
Johnson & Johnson raised its full-year earnings forecast on Tuesday as it reported higher third-quarter sales of psoriasis treatment Stelara and cancer drug Imbruvica while attempting to alleviate investor concerns over mounting legal challenges.
Former Thomas Cook boss defends record after firm’s collapse
The former chief executive of bankrupt travel firm Thomas Cook said on Tuesday he understood public anger over his pay but defended his record, saying he had worked tirelessly to try to save the company.
Futures rise as third-quarter earnings start on strong note
U.S. stock index futures rose on Tuesday, as the third-quarter earnings season got off to an upbeat start with robust reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson.
JPMorgan profit boosted by bond trading, strong underwriting
JPMorgan Chase & Co reported an 8.4% rise in quarterly profit on Tuesday, driven by higher revenue from its bond trading business and gains in debt and equity underwriting.
J&J bumps up full-year profit view on strength of cancer drugs
Johnson & Johnson on Tuesday boosted its full-year adjusted profit forecast, as multi-billion dollar sales of its cancer drugs Darzalex and Imbruvica helped it beat estimates for third-quarter profit.
